Skip to main content

PD Dr. med. Dr. rer. biol. hum. Bettina Hohberger

Augenklinik

PD Dr. med. Dr. rer. biol. hum. Bettina Hohberger

Consultant and Molecular Scientist

Education, Training and Academic Positions

2021

Habilitation at the Medical Faculty of the FAU Erlangen-Nürnberg (Ophthalmology): Examinations regarding the etiology of glaucoma.

2020

PhD in molecular medicine at the Institute of Anatomy, FAU Erlangen-Nürnberg (magna cum laude).

Since 09/2019                         

Vice speaker of the AG young DOG (Deutsche Ophthalmologische Gesellschaft)

Since 01/2018                         

Consultant at the Department of Ophthalmology, FAU Erlangen-Nürnberg, Germany

Since 09/2017                         

Ophthalmologist of the Erlangen Glaucoma Registry

2012-2018                              

Resident at the Department of Ophthalmology, FAU Erlangen-Nürnberg, Germany

2011                                      

Dissertation at the Department of Ophthalmology, FAU Erlangen-Nürnberg, Germany

2005-2010                              

Studies of molecular medicine at the FAU Erlangen-Nürnberg, Germany

2002-2009                              

Studies of medicine at the FAU Erlangen-Nürnberg, Germany

 

2022                   

  • Nomination: Paper of the Year award der Biophysical Society: Physical phenotype of blood cells is altered in COVID-19
  • Heidelberg Engineering X-treme Research Award

2022                   

  • Paper of the Year award of the Biophysical Society: Physical phenotype of blood cells is altered in COVID-19.
  • Heidelberg Engineering X-treme Research Award

2020                   

  • nomination for the Galenus-von-Pergamon-Preis, category: basic science: agonistic ß2-adrenergic autoantibodies: a novel target in glaucoma therapy.

2019                   

  • Research award of the „Bundesverbandes Auge“, Berlin, Germany
  • Poster of the day award of the „Deutsche Ophthalmologische Gesellschaft“ (DOG), Berlin, Germany: MIGS - Therapeutic success of Xen45 gel stent implantation with mitomycin C in combination with cataract surgery
  • Best Presentation Award, SFO-FEOph, Paris, France: MIGS - what do we know about Xen gel stents?

2018                   

  • DOG Glaucoma Research award 2018, founded by Santen GmbH, Bonn, Germany: Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma
  • Poster of the day award of the „Deutsche Ophthalmologische Gesellschaft“ (DOG) Bonn, Germany: Erlangen Glaucoma Registry: longtime observation of intraocular pressure in normal subjects

2017                   

  • Poster of the day award of the „Deutsche Ophthalmologische Gesellschaft“ (DOG), Berlin, Germany: MIGS - Therapeutic success of combined Xen Gel Stent implantation with cataract surgery
  • Julius-Springer-Award of Ophthalmology 2017, Berlin, Germany: Measurements of recovery time after 25 Hz temporal contrast adaptation as new tool for monitoring glaucoma progress.

2015                   

  • Poster of the day award of the „Deutsche Ophthalmologische Gesellschaft“ (DOG), Berlin, Germany: Measurements of recovery time after 25 Hz temporal contrast adaptation as new tool for monitoring glaucoma progress.

2012                    

  • Graduation award of the Scientific Foundation for human medicine at the University of Erlangen-Nürnberg, Erlangen, Germany                 
  • Graduation award of the Hermann-Wacker Foundation, Berlin, Germany